The DOJ alleged that Walgreens submitted false billing requests to Medicare, Medicaid and other federal health programs between 2009 and 2020. According to the DOJ, Walgreens had improperly billed for prescriptions that were processed but never picked up by the patients. Despite not providing the medications, the pharmaceutical company collected tens of millions of dollars from federal health programs.
As a result, the federal government will recover $91.9 million from the settlement, while individual states will receive a total of $14.9 million to be distributed through separate agreements with states.
The case was brought to light through whistleblower actions under the False Claims Act by Steve Turck, former Walgreens pharmacy manager and Andrew Bustos, former pharmacy district supervisor. Under the provisions of the law, Turck will receive $14.9 million for his role in exposing the alleged fraud and Bustos will receive $1.6 million.
Walgreens has not responded to Becker’s request for comment at this time.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.